Effects of the Roche PKC inhibitor on luciferase production and IL-8 production in transfected U937 clones
| Treatment | IC502-a | ||
|---|---|---|---|
| U937/pHIVlucneo | U937/pIL8lucneo | IL-8 production | |
| μM | |||
| 5 ng/ml TNF-α | >1.0 | >1.0 | >1.0 |
| 0.1 μM PMA | 0.28 (0.23–0.34) | 0.21 (0.13–0.38) | 0.11 (0.11–0.12) |
↵2-a Numbers in parentheses indicate 95% confidence limits.